Left Ventricular Enlargement Procedure in a Patient with Diffuse-Type Hypertrophic Cardiomyopathy: A Case Report

Overview

Journal J Chest Surg

Specialty Cardiology & Vascular Diseases

Date 2022 Feb 22

PMID 35193118

Authors

Dong Youb Han

Sung Jun Park

Sung-Ho Jung

Affiliations

Soon will be listed here.

Abstract

Surgical septal myectomy is the preferred treatment option for patients with medically intractable obstructive hypertrophic cardiomyopathy. Extended transaortic septal myectomy is a widely performed surgical procedure for patients with subaortic obstruction. The transapical approach may provide an alternative surgical option in less common phenotypes, such as apical hypertrophy or long-segmental septal hypertrophy. In this report, we describe a case of a procedure performed to achieve left ventricular enlargement procedure using a combined transaortic and transapical dual approach in a patient with diffuse-type hypertrophic cardiomyopathy with apical aneurysm and mid-cavity obstruction.

References

Minami Y, Kajimoto K, Terajima Y, Yashiro B, Okayama D, Haruki S . Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011; 57(23):2346-55. DOI: 10.1016/j.jacc.2011.02.033. View

Schaff H, Brown M, Dearani J, Abel M, Ommen S, Sorajja P . Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2010; 139(3):634-40. DOI: 10.1016/j.jtcvs.2009.07.079. View

Nguyen A, Schaff H, Miranda W, Tajik A . The First Operation for Apical Hypertrophic Cardiomyopathy-Dr Dwight McGoon, 1972. Ann Thorac Surg. 2017; 104(2):e133-e136. DOI: 10.1016/j.athoracsur.2017.02.053. View

Hang D, Schaff H, Ommen S, Dearani J, Nishimura R . Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2017; 155(5):2096-2102. DOI: 10.1016/j.jtcvs.2017.10.054. View

Maron B . Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation. 2007; 116(2):196-206. DOI: 10.1161/CIRCULATIONAHA.107.691378. View